Upload
others
View
6
Download
0
Embed Size (px)
Citation preview
Appendix J - Data Validation
Appendix J – Data Validation
1. Introduction
This data validation appendix summarises the data quality objectives (DQOs), established for the datato support residential produce sampling and then assesses the reliability of the field work proceduresand laboratory analytical results using the data quality indicators (DQIs).
1.1. Data Quality Objectives
The National Environment Protection Measure (NEPM, Schedule B2 Guideline on Site
Characterisation - 2013) states that the nature and quality of the data collected for a particular
assessment will be determined by the Data Quality Objectives (DQOs). The NEPM and the AustralianStandard AS4482.1-2005 reference the US EPA Guidance on Systematic Planning Using the Data
Quality Objectives Process (US EPA, 2006) which defines the DQO process. The US EPA defines
the process as ‘a strategic planning approach based on the Scientific Methods that is used to prepare
for a data collection activity. It provides a systematic procedure for defining the criteria that a data
collection design should satisfy, including when to collect samples, where to collect samples, the
tolerable level of decision errors for the study, and how many samples to collect.’
To define the purpose, type, quantity and quality of data required for the residential produce sampling,the seven step data quality objectives (DQOs) approach, as described in the NEPM 2013, wasadopted.
The seven steps of the DQO process for the current RAAF Base RAAF Base Tindal Investigationrelating to these works are summarised below:
Table 1: Data Quality Objectives
Quality objectives
1. State the Problem
PFAS contamination sources have been identified at RAAF Base Tindal and investigations to date have
identified contaminated soil and groundwater in the vicinity of known source areas. The nature and extent of
PFAS contamination to offsite areas within the Environmental Investigation Area (EIA) has identified PFAS in
groundwater, surface waters, sediment, animal biota (whole fish) and animal products (chicken and duck
eggs). The Ecological Risk Assessment (ERA) will utilise PFAS concentrations either measured or estimated
at the POE to estimate exposures to ecological receptors. The identified areas where PFAS concentrations in
media is not known or the CSM requires further refinement includes:
• Data are needed for the ERA to characterize PFAS concentrations in aquatic and terrestrial biota
across the EIA, and to estimate exposures and risk to upper trophic level receptors.
• Given the tropical climate of the Tindal/Katherine area, surface water flows and groundwater recharge
rates will have a strong seasonal variations that are likely to influence PFAS concentrations in
groundwater, surface water, sediments, food sources and receptor behaviours and exposures.
Appendix J – Data Validation
Quality objectives
2. Identify the goal of the study
The purpose of the broader investigation is to understand the nature and extent of PFAS contamination as a
result of Defence activities.
The purpose of the ERA investigation is to understand the nature and extent of PFAS contamination in media
at the POE within the EIA where identified receptor populations may be exposed.
The ERA will rely on specific information that may be area or receptor specific, therefore data collected from
site media including surface water, sediment, soil, and biota tissue is essential.
The DSI will provide sufficient information on the sources of PFAS contamination, the migration pathways and
the current extent of contamination to enable a robust site model to be developed. The outcomes of the ERA
will guide management strategies where required.
3. Identify information inputs
• Recent and ongoing investigations will provide:
o CSM information relating to the site history, sources and use of PFAS contaminant
materials, and determine the nature and extent of contamination in soil, water, and
sediment.
o Surface water and groundwater flow regimes, to develop the conceptual site model
about the potential migration pathways of contamination from source areas towards
ecological receptors.
o Preliminary data relating to PFAS contamination of site biota including terrestrial and
aquatic plants, terrestrial invertebrates, small mammals, aquatic invertebrates, and fish.
o Relevant screening criteria, where established, to reflect plausible exposure routes.
4. Define the boundary of the study
Based on the potential for contaminated surface water or shallow groundwater to migrate west north-west
towards Katherine River, the broad study area includes land and waterways on RAAF Base Tindal and the
area between the Base and Katherine River. An approximate buffer of 1km across the western side of
Katherine River has been included.
Appendix J – Data Validation
Quality objectives
5. Develop a decision rule
Primary environmental samples will be collected and analysed by the laboratories for the full suite of PFAScompounds.
Terrestrial biota samples
• Absolute concentrations to evaluate the exposure where ingestion of terrestrial biota (i.e.,
invertebrates, plants, amphibians, reptiles, small mammals) may occur, to allow the quantitative
assessment of ecological risk.
• Paired results (with amphibian biota) will be used to evaluate the potential for accumulation in
amphibians. Measured concentrations in amphibians will be used to assess the potential risk from
ingestion of amphibians to upper trophic level receptors (i.e., reptiles, mammals and birds).
• Paired results (with reptile biota) will be used to evaluate the potential for accumulation in reptiles.
Measured concentrations in reptiles will be used to assess the potential risk from ingestion of reptiles
to upper trophic level receptors (i.e., reptiles, mammals and birds).
• Paired results (with small mammal biota) will be used to evaluate the potential for accumulation in
small mammals. Measured concentrations in small mammals will be used to assess the potential risk
from ingestion of small mammals to upper trophic level receptors (i.e., reptiles, mammals and birds).
• Paired results (with reptile and bird egg data) will be used to evaluate the potential for accumulation in
reptile and bird eggs. Measured concentrations in reptile and bird eggs will be used to assess the
potential risk to upper trophic level receptors from ingestion of reptile and bird eggs.
Aquatic biota samples
• Absolute concentrations to evaluate the exposure where ingestion of aquatic biota (i.e., invertebrates,
plants, fish, amphibians) may occur, to allow the quantitative assessment of ecological risk.
• Paired results (with fish biota) will be used to evaluate the potential for accumulation in fish.
Measured concentrations in fish will be used to assess the potential risk from ingestion of fish to upper
trophic level (i.e., piscivorous amphibians, reptiles, mammals and birds).
• Paired results (with amphibian biota) will be used to evaluate the potential for accumulation in
amphibians. Measured concentrations in amphibians will be used to assess the potential risk from
ingestion of amphibians to upper trophic level receptors (i.e., reptiles, mammals and birds).
• Paired results (with reptile biota) will be used to evaluate the potential for accumulation in reptiles.
Measured concentrations in reptiles will be used to assess the potential risk from ingestion of reptiles
to upper trophic level receptors (i.e., reptiles, mammals and birds).
• Paired results (with small mammal biota) will be used to evaluate the potential for accumulation in
small mammals. Measured concentrations in small mammals will be used to assess the potential risk
from ingestion of small mammals to upper trophic level receptors (i.e., reptiles, mammals and birds).
Data set for POE will be sufficient to allow statistical analysis if required.
Appendix J – Data Validation
Quality objectives
6. Specify performance of acceptance criteria
The assessment as a whole (including consideration of previous assessments) must reliably characterise the
sources of contamination from the Base and described the risk that the contamination may pose to human or
ecological receptors. In order to achieve that, there must be multiple lines of evidence to support location of
source areas; the characterisation of the nature and extent of the residual source and associated surface water
or ground water impact; the significance of the risk that that contamination currently poses to relevant
receptors; and predictions of future impacts.
The ERA assessment as a whole must reliably characterise the contaminant concentrations at the point of
exposure, either via direct measurement or calculation, to quantify the potential intake and associated risk to
ecological receptors within the EIA.
As consistent with NEPM guidance, the uncertainties associated with each step in the risk assessment
process, particularly site conditions, ecological exposure and chemical toxicity, will be discussed in terms of the
variability in the assumptions and associated influence on the estimates of risk.
7. Develop a plan for obtaining the data
The methodology and rationale for obtaining relevant data was developed and approved prior toimplementation.
1.2. Data Quality Indicators
An assessment of the reliability of field procedures and laboratory analytical results outlined throughthe DQOs has been undertaking using the DQIs of precision, accuracy, representativeness,completeness and comparability. A brief outline of the DQIs is presented below.
Precision – All Coffey field staff to implement Coffey standard operating procedures (SOPs) orproject specific procedures appropriate for the task being undertaken. All laboratories used toundertake analysis are NATA accredited for the analytes being tested for. An appropriate number ofintra-laboratory and inter-laboratory replicate samples were collected and analysed and are within theacceptable limits of 1 in 20.
Accuracy – All Coffey staff to follow the appropriate procedures for the tasks being undertaken. Tripblanks and equipment rinsate blank samples collected and results of which are to be satisfactory. Alllaboratories used are to be NATA accredited and the use of NATA endorsed methods, includingappropriate method blanks, laboratory control samples, laboratory spikes and duplicates, and theresults of which satisfy the defined criteria of acceptability.
Representativeness – A sufficient number of samples are to be collected and analysed from eachmedia to adequately achieve the overall DSI objectives.
Completeness – All Coffey staff to follow procedures appropriate to the task being performed, alongwith the appropriate documentation. All identified areas of environmental concern to be assessed withchemical analysis for relevant chemicals of potential concern from targeted and systematic samplinglocations. All samples to be under proper custody between the field and laboratory. The data obtainedfrom the laboratory is considered relevant and usable.
Comparability – All Coffey staff to follow the appropriate procedures for the task being undertakenand complete all sampling documentation. All analyte holding times to be complied with and samples
Appendix J – Data Validation
properly and adequately preserved. All laboratory analysis to use the correct methods, along withappropriate limits of reporting (LORs).
The DQIs for the field works and laboratory analysis are presented in Table 2 and Table 3.
Table 2: Field Works Quality Control Criteria
Item Comments
Intra-laboratory
duplicates
Inter-laboratoryduplicates(triplicates)
Intra-laboratory field duplicates were collected at a minimum frequency of one sample per
twenty samples collected (5%). The analytical results of the primary sample and
duplicate/triplicate samples will be compared to assess the precision of the sampling
protocol and to provide an indication of variation in the sample source.
Repeatability will be assessed by calculating the relative percentage difference (RPD)
between the primary and duplicate results. Where the RPD is greater than 30%, the
potential causes of variability has been reviewed.
Trip blanks Trip blanks are a check on sample contamination originating from containers, sample
transport, shipping and site conditions. The trip blank will be prepared in a clean
environment (office or warehouse) and remain with the sample containers during sampling
and during the return trip to the laboratory. At no time during these procedures will the
blanks be opened. Upon return to the laboratory the blank will be analysed, if needed, as
any other field sample. As PFAS is not volatile, a reduced blank frequency is considered
appropriate and a single trip blank per sample batch will be transported and analysed.
Detectable concentrations of PFAS in a trip blank sample will trigger review of sample
container types, transport procedures and UHP water quality. The concentration and
compound detected will be considered in reviewing the potential impact of transport related
cross-contamination of the assessment data quality.
Rinsate blanks Rinsate samples will be prepared in the field using empty bottles and the distilled
water/potable water used for the cleaning of non-disposable sampling equipment. These
samples will be a check of field decontamination procedures. A rinsate sample will be
collected and analysed for each day of field work, where non-disposable sampling
equipment has been used.
Detectable concentrations of PFAS in a rinsate blank sample will trigger review of
decontamination procedures, equipment materials, sample container types and UHP water
quality. The concentration and compound detected will be considered in reviewing the
potential impact of transport related cross-contamination of the assessment data quality.
Table 3: Laboratory Quality Control Criteria
Data Type Comments and Acceptable Control Limits
Sample Analysis All sample analyses were conducted using NATA certified laboratories which implementeda quality control plan in accordance with NEPM (2013).
Holding times Maximum acceptable sample holding times for PFAS in biota is 180 days.
Laboratorydetection limits
All laboratory detection limits to be less than the site investigation criteria.
Appendix J – Data Validation
Data Type Comments and Acceptable Control Limits
LaboratoryBlanks
Laboratory blanks to be analysed at a rate of 1 in 20, with a minimum of one analysed perbatch.
Concentration of analytes to be less than the laboratory detection limits.
LaboratoryDuplicates
Laboratory duplicates to be analysed at a rate of 1 in 20, with a minimum of one analysedper batch. RPDs to be less than 30%.
LaboratoryControl Samples(LCS)
LCSs to be analysed at a rate of 1 in 20, with a minimum of one analysed per analyticalbatch.
Control limits: 50 to 150 % acceptable recovery
Matrix spikes Matrix spike duplicate prepared by dividing a field sample into two aliquots, then spikingeach with identical concentrations of the analytes at a rate of 1 in 20.
Matrix spikecontrol limits:
50–150 % acceptable recovery.
Matrix spikeduplicates:
RPDs <50%
1.3. Field Quality Assurance Quality Control
Field Quality Assurance Procedures
Field quality assurance involves all the planned actions, procedures, checks and decisions whichhave been made and undertaken through quality control measures to ensure the representativenessand integrity of collected samples is that of the true conditions.
Sample Collection
All Coffey environmental scientists/engineers were suitably qualified, trained and experienced for thesample collection undertaken. Sampling of each matrix was undertaken with reference to the projectspecific procedures.
Sampling Methodology
The adopted sampling methods for each media (e.g. biota, soil, sediments, groundwater and surfacewater) is presented in Appendix F.
All samples were collected using a new disposable nitrile glove. Each sample was collected in alaboratory supplied jar or bottle appropriate to the analysis required.
Each sample was labelled using a unique sample identifier, project reference and date of samplecollection, as directed by Defence.
Sample Transport and Preservation
To maintain sample integrity, all samples were placed into laboratory prepared containers suitable forPFAS and other non-PFAS analysis. Samples were immediately placed into an insulated ice chestcontaining ice, for storage and transportation to the laboratory.
All samples were sent to the laboratories under chain of custody (CoC) documentation.
Appendix J – Data Validation
2. Terrestrial and Aquatic Vegetation
2.1. Samples Collected
Table 1. Type of Quality Assurance Quality Control (QA/QC) Samples Collected
Primary Samples 24
Days of sampling 3
Field Duplicates (at least 1 in 20 samples) 2 inter-laboratory
Trip Blanks (at least 1 per sampling event) -
Equipment Rinsate (at least
1/day/matrix/equipment)
1
2.1.1. Samples Analysed
24 samples were collected and sent to the primary laboratory over 3 days of sampling.
2.1.2. Inter-Laboratory and Intra-Laboratory Duplicates
ITEM QUESTION YES NO (Comment
below)
1 Were an Adequate Number of inter-laboratory and inter-laboratory
duplicates analysed for each chemical?
2 Were RPDs within Control Limits?
< 30% for concentrations
Comments
Duplicate samples of terrestrial and aquatic plant samples were reported within acceptable limits(<30%).
Appendix J – Data Validation
2.1.3. Trip Blanks
ITEM QUESTION YES NO (Comment
below)
1 Was a trip blank collected on each day of sample?
2 Were the Trip Blanks free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
No dedicated trip blank was collected during the sampling carried out through the sampling event.However, the rinsate blank that was collected was free of contamination. Therefore, this demonstratesthat cross contamination was unlikely to have occurred during sample storage and transport.
2.1.4. Rinsate Blanks
ITEM QUESTION YES NO (Comment
below)
1 Were Equipment Rinsates collected and analysed every
day/event/equipment?
2 Were the Equipment Rinsates free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
Collection of terrestrial and aquatic plant samples was carried out in conjunction with terrestrialinvertebrate sampling. Batches of flora and fauna samples were sent together, with one rinsate blankfor the sampling event. Rinsate blank results are presented and discussed in the QAQC section forterrestrial invertebrates of this report.
Re-usable equipment was typically not used for collection of vegetation samples. Concentrations forall analytes were below the laboratory LOR for rinsate blanks where relevant.
The rinsate results indicated that the decontamination procedures, where relevant, were acceptableand it is considered that there is a low potential for cross-contamination to have impacted on thelaboratory results.
Appendix J – Data Validation
In summary, the field QC results are considered generally acceptable for the purposes of thisinvestigation.
Field QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
2.2. Laboratory Quality Assurance Quality Control
2.2.1. Laboratories
ITEM QUESTION YES NO (Comment below)
1 Was a NATA registered laboratory used?
2 Did the laboratory perform the requested tests?
3 Were the laboratory methods adopted NATA endorsed?
4 Were the appropriate test procedures followed?
5 Were the reporting limits satisfactory?
6 Was the NATA Seal on the reports?
7 Were the reports signed by an authorised person?
Comments
Eurofins – Eurofins has been adopted as the primary laboratory for analysis of all matrices. Eurofins isa NATA accredited laboratory (NATA accreditation number 1261) for the media and analytes requiringanalysis.
Precision / Accuracy of the Laboratory Report Satisfactory
Partially Satisfactory
Unsatisfactory
2.2.2. Sample Handling
ITEM QUESTION YES NO (Comment
below)
1 Were the sample holding times met?
2 Were the samples in proper custody between the field and reaching
the laboratory?
3 Were the samples properly and adequately preserved?
This includes keeping the samples chilled, where applicable.
4 Were the samples received by the laboratory in good condition?
Appendix J – Data Validation
Comments
Nil
Sample Handling was: Satisfactory
Partially Satisfactory
Unsatisfactory
2.2.3. Laboratory (Method) Blanks
The method blank allows assessment for potential method bias for relevant analytes. A method blankis the component of the analytical signal from each analytical method that is from laboratoryequipment (reagents, glassware and analytical instruments etc.). The method blank is determined bythe laboratories through running solvents and reagents in exactly the same manner as the samples.
At least one method blank should be run per 20 samples analysed, with a minimum of one methodblank per sample batch.
All laboratory method blank results reported concentrations of contaminants below the laboratoryreporting limits.
2.2.4. Laboratory Duplicates
To provide an estimate of the analysis method precision and duplicate sample heterogeneity, asample from the same batch is duplicated and analysed for a targeted analyte.
All internal laboratory duplicates analysed were within acceptable limits (<30% RPD).
2.2.5. Laboratory Control Samples
Laboratory control samples are prepared in the laboratory and comprise either a known analyteconcentration within a proven matrix or a control matrix spiked with analytes representative of thetarget analyte. The laboratory control sample percent recovery is reported along with the primarysample data to assess method accuracy for all targeted analytes.
Laboratory control samples are required to be processed per 20 samples analysed, with a minimum ofone laboratory control sample run per batch of samples.
All laboratory control sample analyses were within the acceptable range (>50%).
2.2.6. Matrix Spikes
A matrix spike is undertaken to document the effect of the matrix on the performance of the methodused. The matrix spike is the addition of a known analyte concentration to the target matrix prior toextraction or digestion. If a poor percentage recovery of a matrix spike is reported below the expectedanalytical method performance, the laboratory should investigate the likely cause. If, afterinvestigation, the poor matrix spike remains and is reported to the client, an explanation documentingthe limitations of the method for recovery of the target analyte from that particular matrix needs to beprovided. If the laboratory control sample recovery is acceptable for the same analyte, this mayindicate that it is the matrix causing the poor recovery and not the method.
All matrix spike analyses were within the adopted 50% – 150% acceptability criteria adopted.
Appendix J – Data Validation
2.2.7. Surrogate Recoveries
Surrogate spikes are a means of the laboratory checking that no gross errors have taken placethroughout the analysis procedure, causing losses of the target analytes. The laboratory undertakessurrogate spikes by adding a known quantity of compounds with similar properties and behaviour tothe target compounds, but which are not expected to be found in field samples.
Surrogate spikes are only appropriate for organic analysis and are added to all samples beinganalysed prior to the extraction process. A percent recovery is calculated for each surrogate,providing the analytical method accuracy of extraction of the target analytes from samples.
The collated laboratory data for surrogate recoveries reported 337 surrogates out of a total of 552surrogate analyses undertaken outside of the acceptable recovery limits (50% to 150%). A total of39% of surrogate recoveries were within acceptable limits. These discrepancies were for a number ofPFAS compounds. For the three primary compounds of concern (PFOS, PFOA & PFHxS), a total of57% (31 out of 72) of surrogate recoveries were within acceptable limits.
The surrogate outliers for key compounds were all reported below the lower acceptable limit of 50%,or were not reported due to interference. When surrogate outliers occur, the laboratory apply acorrection factor adjustment to the result, which can result in the laboratory over-reporting theconcentration. For this reason, and because maximum concentrations of plant material have beenadopted for the modelling in this ERA, mean that a conservative approach has been applied whenassessing ecological risks to terrestrial and aquatic plants.
2.2.8. Summary of Internal Laboratory Quality Control
A summary of the internal laboratory quality control results is provided in the following tables
ITEM QUESTION YES NO (Comment
below)
1 Were the laboratory blanks/reagents blanks free of contamination?
2 Were the spike recoveries within control limits?
3 Were the RPDs of the laboratory duplicates within control limits?
4 Were the surrogate recoveries within control limits?
Table 2. Summary of internal laboratory QC results
QC test Total Analyses Number outside of
Acceptable Criteria
% of analyses acceptable
Method Blanks 28 0 100%
Laboratory
Duplicates
56 0 100%
Laboratory
Control Samples
28 0 100%
Matrix Spikes 28 0 100%
Surrogates 552 337 38.9%
Totals 692 337 51.3%
Appendix J – Data Validation
The review of the laboratory internal quality control testing undertaken indicated that the overallcompleteness for the internal laboratory quality control results was 51.3%. As discussed in Section1.3.7, the low surrogate recoveries reported have likely added a level of conservatism to the results.The data is therefore considered of an acceptable quality to use in the report.
Laboratory internal QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
2.3. Summary of Vegetation Data Quality Review
In general, the data quality of the terrestrial and aquatic plant sampling was considered to beacceptable in relation to low potential for cross contamination during sampling, followed by suitabletransport to a NATA certified laboratory for analysis within holding times. The surrogate recoverieswere typically low and many were below the acceptance target of 50% or labelled as “Interference”.This may indicate low confidence in the absolute values of PFAS compounds in native vegetation. Toaccount for this potential variability, results should be applied conservatively.
Ecological Risk Assessment
Aquatic and Terrestrial Plant Tissue
Quality Control - RPDs
DoD, RAAF Base Tindal
Chem_Group ChemName Units
PFAS Perfluoro-n-octanoic acid (PFOA) µg/kg
Perfluoro-n-hexane sulfonic acid (PFHxS) µg/kg
Perfluoro-n-octane sulfonic acid (PFOS) µg/kg
Perfluorobutane sulfonic acid (PFBS) µg/kg
Perfluoro-n-decanoic acid (PFDA) µg/kg
Perfluoro-n-dodecanoic acid (PFDoDA) µg/kg
Perfluoro-n-heptanoic acid (PFHpA) µg/kg
Perfluoro-n-hexanoic acid (PFHxA) µg/kg
Perfluoro-n-nonanoic acid (PFNA) µg/kg
Perfluoro pentanoic acid (PFPeA) µg/kg
Perfluoro-n-undecanoic acid (PFUnDA) µg/kg
1H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/kg
1H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/kg
Ecological Risk Assessment
Aquatic and Terrestrial Plant Tissue
Quality Control - RPDs
DoD, RAAF Base Tindal
Lab Report Number 578707 RN1184142 578707 RN1184142
Field ID
0990_VG173_1
71211
0990_VG173_
171211RPD
0990_VG173_1
71211
0990_VG173_
171211RPD
Sampled Date 13/12/2017 13/12/2017 13/12/2017 13/12/2017
EQL
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.3 <0.3 <0.3 0 <0.3 <0.3 0
0.3 0.4 <0.3 28 <0.3 <0.3 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
0.5 <0.5 <0.5 0 <0.5 <0.5 0
Appendix J – Data Validation
3. Terrestrial Invertebrates
3.1. Samples Collected
Table 3. Type of Quality Assurance Quality Control (QA/QC) Samples Collected
Primary Samples 25
Days of sampling 1
Field Duplicates (at least 1 in 20 samples) 3 intra-laboratory and 2 inter-laboratory
Trip Blanks (at least 1 per sampling event) -
Equipment Rinsate (at least
1/day/matrix/equipment)
1
3.1.1. Samples Analysed
25 samples were collected and sent to the primary laboratory over one day of sampling. Threeduplicate samples were collected and submitted for laboratory analysis.
3.1.2. Inter-Laboratory and Intra-Laboratory Duplicates
ITEM QUESTION YES NO (Comment
below)
1 Were an Adequate Number of inter-laboratory and inter-laboratory
duplicates analysed for each chemical?
2 Were RPDs within Control Limits?
< 30% for concentrations
Comments
Where RPDs were outside the acceptable range, sampling procedures, laboratory analytical methodsand laboratory results were investigated.
There were 84 intra-laboratory and 26 inter-laboratory duplicate pair analyses for PFAS compoundsand 95.5 % were reported within the acceptance target of less than 30 % RPD.
The RPD results from the terrestrial invertebrate sampling were generally considered acceptable andable to be relied on for the report.
Appendix J – Data Validation
3.1.3. Trip Blanks
ITEM QUESTION YES NO (Comment
below)
1 Was a trip blank collected on for each batch of samples?
2 Were the Trip Blanks free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
No dedicated trip blank was collected during the sampling carried out through the sampling event.However, the rinsate blank that was collected was free of contamination. Therefore, this demonstratesthat cross contamination was unlikely to have occurred during sample storage and transport.
3.1.4. Rinsate Blanks
ITEM QUESTION YES NO (Comment
below)
1 Were Equipment Rinsates collected and analysed every
day/event/equipment?
2 Were the Equipment Rinsates free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
Rinsate samples were collected from the field equipment after decontamination. Equipment rinsatesamples were collected by pouring laboratory prepared deionised water over the equipment andcollecting the ‘rinse’ into sample containers. Concentrations of PFOS were reported for three of thefour samples collected, however these concentrations were marginally below the laboratory LOR forrinsate blanks.
The rinsate results indicated that the decontamination procedures were acceptable and it isconsidered that there is a low potential for cross-contamination to have impacted on the laboratoryresults.
Appendix J – Data Validation
In summary, the field QC results are considered generally acceptable for the purposes of thisinvestigation.
Field QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
3.2. Laboratory Quality Assurance Quality Control
3.2.1. Laboratories
ITEM QUESTION YES NO (Comment below)
1 Was a NATA registered laboratory used?
2 Did the laboratory perform the requested tests?
3 Were the laboratory methods adopted NATA endorsed?
4 Were the appropriate test procedures followed?
5 Were the reporting limits satisfactory?
6 Was the NATA Seal on the reports?
7 Were the reports signed by an authorised person?
Comments
Eurofins – Eurofins has been adopted as the primary laboratory for analysis of all matrices. Eurofins isa NATA accredited laboratory (NATA accreditation number 1261) for the media and analytes requiringanalysis.
Precision / Accuracy of the Laboratory Report Satisfactory
Partially Satisfactory
Unsatisfactory
Appendix J – Data Validation
3.2.2. Sample Handling
ITEM QUESTION YES NO (Comment
below)
1 Were the sample holding times met?
2 Were the samples in proper custody between the field and reaching
the laboratory?
3 Were the samples properly and adequately preserved?
This includes keeping the samples chilled, where applicable.
4 Were the samples received by the laboratory in good condition?
Comments
Nil
Sample Handling was: Satisfactory
Partially Satisfactory
Unsatisfactory
3.2.3. Laboratory (Method) Blanks
The method blank allows assessment for potential method bias for relevant analytes. A method blankis the component of the analytical signal from each analytical method that is from laboratoryequipment (reagents, glassware and analytical instruments etc.). The method blank is determined bythe laboratories through running solvents and reagents in exactly the same manner as the samples.
At least one method blank should be run per 20 samples analysed, with a minimum of one methodblank per sample batch.
All laboratory method blank results reported concentrations of contaminants below the laboratoryreporting limits.
3.2.4. Laboratory Duplicates
To provide an estimate of the analysis method precision and duplicate sample heterogeneity, asample from the same batch is duplicated and analysed for a targeted analyte.
100% of internal laboratory duplicates analysed were within acceptable limits (<30% RPD).
Appendix J – Data Validation
3.2.5. Laboratory Control Samples
Laboratory control samples are prepared in the laboratory and comprise either a known analyteconcentration within a proven matrix or a control matrix spiked with analytes representative of thetarget analyte. The laboratory control sample percent recovery is reported along with the primarysample data to assess method accuracy for all targeted analytes.
Laboratory control samples are required to be processed per 20 samples analysed, with a minimum ofone laboratory control sample run per batch of samples.
All laboratory control sample analyses were within the acceptable range (>50%).
3.2.6. Matrix Spikes
A matrix spike is undertaken to document the effect of the matrix on the performance of the methodused. The matrix spike is the addition of a known analyte concentration to the target matrix prior toextraction or digestion. If a poor percentage recovery of a matrix spike is reported below the expectedanalytical method performance, the laboratory should investigate the likely cause. If, afterinvestigation, the poor matrix spike remains and is reported to the client, an explanation documentingthe limitations of the method for recovery of the target analyte from that particular matrix needs to beprovided. If the laboratory control sample recovery is acceptable for the same analyte, this mayindicate that it is the matrix causing the poor recovery and not the method.
All matrix spike recoveries were within acceptable limits.
3.2.7. Surrogate Recoveries
Surrogate spikes are a means of the laboratory checking that no gross errors have taken placethroughout the analysis procedure, causing losses of the target analytes. The laboratory undertakessurrogate spikes by adding a known quantity of compounds with similar properties and behaviour tothe target compounds, but which are not expected to be found in field samples.
Surrogate spikes are only appropriate for organic analysis and are added to all samples beinganalysed prior to the extraction process. A percent recovery is calculated for each surrogate,providing the analytical method accuracy of extraction of the target analytes from samples.
The collated laboratory data for surrogate recoveries reported 115 surrogates (out of a total of 575surrogate analyses undertaken) outside acceptance targets. These discrepancies were for a numberof PFAS compounds, however only one of these discrepancies was for a key compounds (PFOS)indicating that the data set was acceptable for the purposes of supporting the outcomes of the report.
3.2.8. Summary of Internal Laboratory Quality Control
A summary of the internal laboratory quality control results is provided in Table 4 and Table 5.
Appendix J – Data Validation
Table 4: Summary of Internal Laboratory Quality Control
ITEM QUESTION YES NO (Comment
below)
1 Were the laboratory blanks/reagents blanks free of contamination?
2 Were the spike recoveries within control limits?
3 Were the RPDs of the laboratory duplicates within control limits?
4 Were the surrogate recoveries within control limits?
Table 5: Summary of internal laboratory QC results
QC test Total Analyses Number outside of
Acceptable Criteria
% of analyses acceptable
Method Blanks 28 0 100%
Laboratory Duplicates 84 0 100%
Laboratory Control Samples 28 0 100%
Matrix Spikes 56 0 100%
Surrogates 575 235 (1 for PFOS,
PFOA or PFHxS)
60% (99%)
Totals 771 235 69.7%
The review of the laboratory internal quality control testing undertaken indicated that the overallcompleteness for the internal laboratory quality control results was 69.7%. However as most of thesurrogate outlies are not for key PFAS compounds and without the precursor and fluorotelemersurrogate outliers reported, over 99% of internal laboratory quality control results were acceptable.The data is therefore considered of an acceptable quality to use in the report.
Laboratory internal QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
3.3. Summary of Terrestrial Invertebrate Data QualityReview
In general, the data quality of the terrestrial invertebrate sampling was considered to be acceptable.Surrogate recoveries were poor for precursor compounds and fluorotelemers, but suitable for PFOSand PFOA, which are the compounds applied quantitatively in this risk assessment.
Ecological Risk Assessment
Terrestrial Invertebrates
Quality Control - Blanks
DoD, RAAF Base Tindal
Lab Report Number 578676
Field ID 0990_QC3IV_171213
Sampled_Date/Time 13/12/2017
Sample Type Rinsate - bug sorting tray
Chem_Group ChemName Units EQL
PFAS Perfluoro-n-octanoic acid (PFOA) µg/L 0.01 <0.01
Perfluoro-n-hexane sulfonic acid (PFHxS) µg/L 0.01 <0.01
Perfluoro-n-octane sulfonic acid (PFOS) µg/L 0.01 <0.01
PFHxS and PFOS (Sum of Total) µg/L 0.01 <0.01
Perfluorobutane sulfonic acid (PFBS) µg/L 0.01 <0.01
Perfluorobutanoic acid (PFBA) µg/L 0.05 <0.05
Perfluoro-n-decane sulfonic acid (PFDS) µg/L 0.01 <0.01
Perfluoro-n-decanoic acid (PFDA) µg/L 0.01 <0.01
Perfluoro-n-dodecanoic acid (PFDoDA) µg/L 0.01 <0.01
Perfluoropentane sulfonic acid (PFPeS) µg/L 0.01 <0.01
Perfluoro-n-heptane sulfonic acid (PFHpS) µg/L 0.01 <0.01
Perfluoro-n-heptanoic acid (PFHpA) µg/L 0.01 <0.01
Perfluoro-n-hexanoic acid (PFHxA) µg/L 0.01 <0.01
Perfluoro-n-nonanoic acid (PFNA) µg/L 0.01 <0.01
Perfluorooctan esulfonamide (PFOSA) µg/L 0.05 <0.05
Perfluoro pentanoic acid (PFPeA) µg/L 0.01 <0.01
Perfluoro-n-tetradecanoic acid (PFTeDA) µg/L 0.01 <0.01
Perfluoro-n-tridecanoic acid (PFTriDA) µg/L 0.01 <0.01
Perfluoro-n-undecanoic acid (PFUnDA) µg/L 0.01 <0.01
2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/L 0.05 <0.05
2-(N-methylperfluoro-1-octane sulfonamide)-ethanol µg/L 0.05 <0.05
N-Ethyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05
N-Methyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05
1H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/L 0.01 <0.01
1H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/L 0.05 <0.05
1H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/L 0.01 <0.01
1H.1H.2H.2H-perfluorododecanesulfonic acid µg/L 0.01 <0.01
N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/L 0.05 <0.05
N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/L 0.05 <0.05
Lab Report Number 578759 578759 578759 578759 578759 578759 578759 RN1184145 578759 RN1184145
Field ID
0990_IV148_
171213 - A
0990_IV148_1
71213 - BRPD
0990_IV153
_171213 - B
0990_IV153
_171213 - CRPD
0990_IV161
_171213 - A
0990_IV161_
171213 - BRPD
0990_IV143_
171213
0990_IV143
_171213RPD
0990_IV151_
171213
0990_IV151_
171213 RPD
Sampled Date 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017 13/12/2017
Chem_Group ChemName Units EQL
PFAS Perfluoro-n-octanoic acid (PFOA) µg/kg 0.5 <0.5 <0.5 0 0.5 0.6 19 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 0.53 0
Perfluoro-n-hexane sulfonic acid (PFHxS) µg/kg 0.3 <0.5 <0.5 0 46 82 56 <0.3 <0.3 0 <0.3 <0.3 0 6.9 9.9 36
Perfluoro-n-octane sulfonic acid (PFOS) µg/kg 0.3 3.5 4 13 160 150 6 <0.3 <0.3 0 0.7 1.1 44 64 68 6
Perfluorobutane sulfonic acid (PFBS) µg/kg 0.5 <0.5 <0.5 0 3.6 3.4 6 <0.5 <0.5 0 <0.5 <0.5 0 0.9 0.81 11
Perfluorobutanoic acid (PFBA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-decane sulfonic acid (PFDS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-decanoic acid (PFDA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 0.76 0
Perfluoro-n-dodecanoic acid (PFDoDA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoropentane sulfonic acid (PFPeS) µg/kg 0.5 <0.5 <0.5 0 7.9 6.4 21 <0.5 <0.5 0
Perfluoro-n-heptane sulfonic acid (PFHpS) µg/kg 0.5 <0.5 <0.5 0 1.8 1.9 5 <0.5 <0.5 0
Perfluoro-n-heptanoic acid (PFHpA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-hexanoic acid (PFHxA) µg/kg 0.5 <0.5 <0.5 0 0.8 0.8 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 0.51 0
Perfluoro-n-nonanoic acid (PFNA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluorooctan esulfonamide (PFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro pentanoic acid (PFPeA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-tetradecanoic acid (PFTeDA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-tridecanoic acid (PFTriDA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Perfluoro-n-undecanoic acid (PFUnDA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
N-Ethyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
N-Methyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
1H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
1H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
1H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/kg 0.5 <0.5 <0.5 0 0.7 0.5 33 <0.5 <0.5 0 <0.5 <0.5 0 1.6 3.0 61
1H.1H.2H.2H-perfluorododecanesulfonic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
N-Me perfluorooctanesulfonamid oethanol µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0
Appendix J – Data Validation
4. Terrestrial Vertebrates
4.1. Samples Collected
Table 6. Type of Quality Assurance Quality Control (QA/QC) Samples Collected
Primary Samples 63
Days of sampling 3
Field Duplicates (at least 1 in 20 samples) 5 inter lab + 1 intra lab
Trip Blanks (at least 1 per sampling event) -
Equipment Rinsate (at least
1/day/matrix/equipment)
3
4.1.1. Samples Analysed
63 samples were collected and sent to the primary laboratory over three days of sampling. Fiveprimary laboratory duplicate samples and one secondary laboratory were collected and submitted forlaboratory analysis.
4.1.2. Inter-Laboratory and Intra-Laboratory Duplicates
ITEM QUESTION YES NO (Comment
below)
1 Were an Adequate Number of inter-laboratory and inter-laboratory
duplicates analysed for each chemical?
2 Were RPDs within Control Limits?
< 30% for concentrations
Comments
Where RPDs were outside the acceptable range, sampling procedures, laboratory analytical methodsand laboratory results were investigated.
There were 140 intra-laboratory duplicate pair analyses for PFAS compounds and 95% were reportedwithin the acceptance target of less than 30 % RPD.
There were 28 inter-laboratory duplicate pair analyses for PFAS compounds and 53.6% werereported within the acceptance target of less than 30 % RPD.
The RPD discrepancies observed between the primary laboratory samples and secondary laboratoryduplicate samples be attributable to the laboratory methodologies. It is noted that the secondarylaboratory consistently reported concentrations lower than the primary laboratory sample. As theprimary sample reported higher concentrations and these more conservative results have beenadopted for the ERA, this is not considered to have impacted the outcome of the assessment.
The RPD results from the terrestrial vertebrate sampling were generally considered acceptable andable to be relied on for the report.
Appendix J – Data Validation
4.1.3. Trip Blanks
ITEM QUESTION YES NO (Comment
below)
1 Was a trip blank collected on for each batch of samples?
2 Were the Trip Blanks free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
No dedicated trip blank was collected during the sampling carried out through the sampling event.However, the rinsate blanks that were collected were free of contamination. Therefore, thisdemonstrates that cross contamination was unlikely to have occurred during sample storage andtransport.
4.1.4. Rinsate Blanks
ITEM QUESTION YES NO (Comment
below)
1 Were Equipment Rinsates collected and analysed every
day/event/equipment?
2 Were the Equipment Rinsates free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
Rinsate samples were collected from the field equipment after decontamination. Equipment rinsatesamples were collected by pouring laboratory prepared deionised water over the equipment andcollecting the ‘rinse’ into sample containers. Concentrations of PFAS in all rinsate samples werereported below the laboratory limit of reporting.
The rinsate results indicated that the decontamination procedures were acceptable and it isconsidered that there is a low potential for cross-contamination to have impacted on the laboratoryresults.
In summary, the field QC results are considered generally acceptable for the purposes of thisinvestigation.
Field QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
Appendix J – Data Validation
4.2. Laboratory Quality Assurance Quality Control
4.2.1. Laboratories
ITEM QUESTION YES NO (Comment below)
1 Was a NATA registered laboratory used?
2 Did the laboratory perform the requested tests?
3 Were the laboratory methods adopted NATA endorsed?
4 Were the appropriate test procedures followed?
5 Were the reporting limits satisfactory?
6 Was the NATA Seal on the reports?
7 Were the reports signed by an authorised person?
Comments
Eurofins – Eurofins has been adopted as the primary laboratory for analysis of all matrices. Eurofins isa NATA accredited laboratory (NATA accreditation number 1261) for the media and analytes requiringanalysis.
ALS Environmental – ALS has been adopted as the secondary laboratory for analysis. ALS is a NATAaccredited laboratory (NATA accreditation number 825) for all the analytes requiring analysis.
Precision / Accuracy of the Laboratory Report Satisfactory
Partially Satisfactory
Unsatisfactory
4.2.2. Sample Handling
ITEM QUESTION YES NO (Comment
below)
1 Were the sample holding times met?
2 Were the samples in proper custody between the field and reaching
the laboratory?
3 Were the samples properly and adequately preserved?
This includes keeping the samples chilled, where applicable.
4 Were the samples received by the laboratory in good condition?
Comments
Nil
Appendix J – Data Validation
Sample Handling was: Satisfactory
Partially Satisfactory
Unsatisfactory
4.2.3. Laboratory (Method) Blanks
The method blank allows assessment for potential method bias for relevant analytes. A method blankis the component of the analytical signal from each analytical method that is from laboratoryequipment (reagents, glassware and analytical instruments etc.). The method blank is determined bythe laboratories through running solvents and reagents in exactly the same manner as the samples.
At least one method blank should be run per 20 samples analysed, with a minimum of one methodblank per sample batch.
All laboratory method blank results reported concentrations of contaminants below the laboratoryreporting limits.
4.2.4. Laboratory Duplicates
To provide an estimate of the analysis method precision and duplicate sample heterogeneity, asample from the same batch is duplicated and analysed for a targeted analyte.
100% of internal laboratory duplicates analysed by Eurofins and ALS were within acceptable limits(<30% RPD).
4.2.5. Laboratory Control Samples
Laboratory control samples are prepared in the laboratory and comprise either a known analyteconcentration within a proven matrix or a control matrix spiked with analytes representative of thetarget analyte. The laboratory control sample percent recovery is reported along with the primarysample data to assess method accuracy for all targeted analytes.
Laboratory control samples are required to be processed per 20 samples analysed, with a minimum ofone laboratory control sample run per batch of samples.
All laboratory control sample analyses were within the target acceptable range (>50%).
4.2.6. Matrix Spikes
A matrix spike is undertaken to document the effect of the matrix on the performance of the methodused. The matrix spike is the addition of a known analyte concentration to the target matrix prior toextraction or digestion. If a poor percentage recovery of a matrix spike is reported below the expectedanalytical method performance, the laboratory should investigate the likely cause. If, afterinvestigation, the poor matrix spike remains and is reported to the client, an explanation documentingthe limitations of the method for recovery of the target analyte from that particular matrix needs to beprovided. If the laboratory control sample recovery is acceptable for the same analyte, this mayindicate that it is the matrix causing the poor recovery and not the method.
All matrix spike analyses were within the 50% - 150% acceptance target adopted. Recoveries weretypically poorer for precursors and fluorotelemers than for PFOS, PFHxS and PFOA.
Appendix J – Data Validation
4.2.7. Surrogate Recoveries
Surrogate spikes are a means of the laboratory checking that no gross errors have taken placethroughout the analysis procedure, causing losses of the target analytes. The laboratory undertakessurrogate spikes by adding a known quantity of compounds with similar properties and behaviour tothe target compounds, but which are not expected to be found in field samples.
Surrogate spikes are only appropriate for organic analysis and are added to all samples beinganalysed prior to the extraction process. A percent recovery is calculated for each surrogate,providing the analytical method accuracy of extraction of the target analytes from samples.
The collated laboratory data for surrogate recoveries reported 398 surrogates (out of a total of 1,334surrogate analyses undertaken) outside acceptable limits. These discrepancies were for a number ofPFAS compounds, however only 35 of these discrepancies were for key compounds (PFOS, PFOA &PFHxS) indicating that the data set was acceptable for the purposes of supporting the outcomes ofthe report based on PFOS and PFOA toxicity.
4.2.8. Summary of Internal Laboratory Quality Control
A summary of the internal laboratory quality control results is provided in Table 7 and Table 8.
Table 7: Review of Internal Laboratory Quality Control
ITEM QUESTION YES NO (Comment
below)
1 Were the laboratory blanks/reagents blanks free of contamination?
2 Were the spike recoveries within control limits?
3 Were the RPDs of the laboratory duplicates within control limits?
4 Were the surrogate recoveries within control limits?
Table 8: Summary of internal laboratory QC results
QC test Total Analyses Number outside of
Acceptable Criteria
% of analyses
acceptable
Method Blanks 28 0 100%
Laboratory Duplicates 165 0 100%
Laboratory Control Samples 28 0 100%
Matrix Spikes 112 0 100%
Surrogates 1334 397 70.2%
Totals 1667 298 76.2%
The review of the laboratory internal quality control testing undertaken indicated that the overallcompleteness for the internal laboratory quality control results was 76.2%. However as most of thesurrogate outliers are not for key PFAS compounds and without the non-target compound surrogateoutliers reported, over 95% of internal laboratory quality control results were acceptable. The data istherefore considered of an acceptable quality to use in the report.
Appendix J – Data Validation
Laboratory internal QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
4.3. Summary of Terrestrial Vertebrate Data QualityReview
In general, the data quality of the terrestrial vertebrate biota analysis was considered to beacceptable. Minor QC deficiencies in field duplicates (elevated RPDs for some paired samples)indicated a high variability in environmental concentration, indicating that results should be appliedconservatively. Poor surrogate recovery was also noted for many samples and may result in lowerconfidence in the precision of the results, but is considered unlikely to impact on the outcome of thereport when results are applied conservatively.
5. Aquatic Invertebrates, reptiles and mammals(August 2018)
5.1. Samples Collected
Table 9. Type of Quality Assurance Quality Control (QA/QC) Samples Collected
Primary Samples 18
Days of sampling 2
Field Duplicates (at least 1 in 20 samples) 1
Trip Blanks (at least 1 per sampling event) 2
Equipment Rinsate (at least
1/day/matrix/equipment)
1
5.1.1. Samples Analysed
18 samples were collected and sent to the primary laboratory over two day of sampling. Threeduplicate samples were collected and submitted for laboratory analysis
Ecological Risk Assessment
Terrestrial Vertebrates
Quality Control - RPDs
DoD, RAAF Base Tindal
Lab Report Number 592572 592572 592572 592572 592572 592572 592572 592572 592572 592572 592572 ES1810307
Field ID
0990_TV015_1
80328
0990_TV016_1
80328 RPD
0990_TV034_18
0328
0990_TVC15_18
0328 RPD
0990_TV048_1
80328
0990_TV049_1
80328 RPD
0990_TV051_1
80328
0990_TV052_18
0328 RPD
0990_TV108_1
80328
0990_TV110_1
80328 RPD
0990_TVC10_1
80328
0909_TVC11_
180328 RPD
Sampled Date/Time 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018 28/03/2018
Chem_Group ChemName Units EQL
PFAS Perfluoro-n-octanoic acid (PFOA) µg/kg 0.5 <0.5 <0.5 0 0.7 1.0 35 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 4.1 <1.0 122
Perfluoro-n-hexane sulfonic acid (PFHxS) µg/kg 0.3 0.5 0.5 0 75.0 70.0 7 <0.3 <0.3 0 0.7 4.2 143 0.4 <0.3 29 31.0 16.0 64
Perfluoro-n-octane sulfonic acid (PFOS) µg/kg 0.3 9.8 11.0 12 440.0 510.0 15 5.5 7.6 32 21.0 49.0 80 21.0 <0.3 194 1800.0 1330.0 30
Perfluorobutane sulfonic acid (PFBS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 6.8 1.0 149
Perfluorobutanoic acid (PFBA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 24.0 <5.0 131
Perfluoro-n-decane sulfonic acid (PFDS) µg/kg 0.5 <0.5 <0.5 0 7.9 8.1 2 <0.5 <0.5 0 1.8 1.3 32 7.0 <0.5 173 72.0 167.0 79
Perfluoro-n-decanoic acid (PFDA) µg/kg 0.5 <0.5 <0.5 0 2.9 3.0 3 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 6.5 7.0 7
Perfluoro-n-dodecanoic acid (PFDoDA) µg/kg 0.5 <0.5 0.6 18 3.7 3.9 5 <0.5 <0.5 0 <0.5 <0.5 0 2.7 <0.5 138 31.0 26.0 18
Perfluoropentane sulfonic acid (PFPeS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 26.0 5.0 135
Perfluoro-n-heptane sulfonic acid (PFHpS) µg/kg 0.5 <0.5 <0.5 0 13.0 11.0 17 <0.5 <0.5 0 1.0 1.4 33 <0.5 <0.5 0 <0.5 <1.0 0
Perfluoro-n-heptanoic acid (PFHpA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 9.8 2.0 132
Perfluoro-n-hexanoic acid (PFHxA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 3.1 <1.0 102
Perfluoro-n-nonanoic acid (PFNA) µg/kg 0.5 <0.5 <0.5 0 2.4 3.1 25 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <5.0 0
Perfluorooctan esulfonamide (PFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 9.5 <2.0 130
Perfluoro pentanoic acid (PFPeA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 7.0 8.0 13
Perfluoro-n-tetradecanoic acid (PFTeDA) µg/kg 0.5 <0.5 0.6 18 0.7 0.8 13 <0.5 <0.5 0 <0.5 <0.5 0 0.5 <0.5 0 20.0 15.0 29
Perfluoro-n-tridecanoic acid (PFTriDA) µg/kg 0.5 <0.5 <0.5 0 1.0 1.1 10 <0.5 <0.5 0 <0.5 <0.5 0 2.3 <0.5 129 18.0 13.0 32
Perfluoro-n-undecanoic acid (PFUnDA) µg/kg 0.5 <0.5 <0.5 0 3.0 3.5 15 <0.5 <0.5 0 <0.5 <0.5 0 0.9 <0.5 57 <0.5 <2.0 0
2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0
N-Ethyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0
N-Methyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0
1H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0
1H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 5.9 2.0 99
1H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/kg 0.5 <0.5 <0.5 0 2.5 3.6 36 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 1.1 <2.0 0
1H.1H.2H.2H-perfluorododecanesulfonic acid µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0
N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <5.0 0
N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 3.7 <1.0 115
N-Me perfluorooctanesulfonamid oethanol µg/kg 0.5 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0
Ecological Risk Assessment
Terrestrial Vertebrates
Quality Control - Blanks
DoD, RAAF Base Tindal
Lab Report Number 592492 592492 592492
Field ID 0990_QCTV001_180328 0990_QCTV002_180328 0990_QCTV003_180328
Sampled_Date/Time 28/03/2018 28/03/2018 28/03/2018
Sample Type Rinsate - Scissors Rinsate - Knife Rinsate - Scalpel
Chem_Group ChemName Units EQL
PFAS Perfluoro-n-octanoic acid (PFOA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-hexane sulfonic acid (PFHxS) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-octane sulfonic acid (PFOS) µg/L 0.01 <0.01 <0.01 <0.01
PFHxS and PFOS (Sum of Total) µg/L 0.01 <0.01 <0.01 <0.01
Perfluorobutane sulfonic acid (PFBS) µg/L 0.01 <0.01 <0.01 <0.01
Perfluorobutanoic acid (PFBA) µg/L 0.05 <0.05 <0.05 <0.05
Perfluoro-n-decane sulfonic acid (PFDS) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-decanoic acid (PFDA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-dodecanoic acid (PFDoDA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoropentane sulfonic acid (PFPeS) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-heptane sulfonic acid (PFHpS) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-heptanoic acid (PFHpA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-hexanoic acid (PFHxA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-nonanoic acid (PFNA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluorooctan esulfonamide (PFOSA) µg/L 0.05 <0.05 <0.05 <0.05
Perfluoro pentanoic acid (PFPeA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-tetradecanoic acid (PFTeDA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-tridecanoic acid (PFTriDA) µg/L 0.01 <0.01 <0.01 <0.01
Perfluoro-n-undecanoic acid (PFUnDA) µg/L 0.01 <0.01 <0.01 <0.01
2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/L 0.05 <0.05 <0.05 <0.05
2-(N-methylperfluoro-1-octane sulfonamide)-ethanol µg/L 0.05 <0.05 <0.05 <0.05
N-Ethyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05 <0.05 <0.05
N-Methyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05 <0.05 <0.05
1H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/L 0.01 <0.01 <0.01 <0.01
1H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/L 0.05 <0.05 <0.05 <0.05
1H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/L 0.01 <0.01 <0.01 <0.01
1H.1H.2H.2H-perfluorododecanesulfonic acid µg/L 0.01 <0.01 <0.01 <0.01
N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/L 0.05 <0.05 <0.05 <0.05
N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/L 0.05 <0.05 <0.05 <0.05
Appendix J – Data Validation
5.1.2. Inter-Laboratory and Intra-Laboratory Duplicates
ITEM QUESTION YES NO (Comment
below)
1 Were an Adequate Number of inter-laboratory and inter-laboratory
duplicates analysed for each chemical?
2 Were RPDs within Control Limits?
< 30% for concentrations
Comments
The RPD results from the August 2018 biota sampling were considered acceptable and able to berelied on for the report.
Appendix J – Data Validation
5.1.3. Trip Blanks
ITEM QUESTION YES NO (Comment
below)
1 Was a trip blank collected on for each batch of samples?
2 Were the Trip Blanks free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
The trip blank results indicate that there is a low potential for cross contamination to have occurredduring sample transport.
5.1.4. Rinsate Blanks
ITEM QUESTION YES NO (Comment
below)
1 Were Equipment Rinsates collected and analysed every
day/event/equipment?
2 Were the Equipment Rinsates free of contaminants?
(If no, comment whether the contaminants present are also detected
in the samples and whether they are common laboratory chemicals.)
Comments
Rinsate samples were collected from the field equipment after decontamination. Equipment rinsatesamples were collected by pouring laboratory prepared deionised water over the equipment andcollecting the ‘rinse’ into sample containers.
The rinsate results indicated that the decontamination procedures were acceptable, and it isconsidered that there is a low potential for cross-contamination to have impacted on the laboratoryresults.
Appendix J – Data Validation
In summary, the field QC results are considered generally acceptable for the purposes of thisinvestigation.
Field QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
5.2. Laboratory Quality Assurance Quality Control
5.2.1. Laboratories
ITEM QUESTION YES NO (Comment below)
1 Was a NATA registered laboratory used?
2 Did the laboratory perform the requested tests?
3 Were the laboratory methods adopted NATA endorsed?
4 Were the appropriate test procedures followed?
5 Were the reporting limits satisfactory?
6 Was the NATA Seal on the reports?
7 Were the reports signed by an authorised person?
Comments
Eurofins – Eurofins has been adopted as the primary laboratory for analysis of all matrices. Eurofins isa NATA accredited laboratory (NATA accreditation number 1261) for the media and analytes requiringanalysis.
Precision / Accuracy of the Laboratory Report Satisfactory
Partially Satisfactory
Unsatisfactory
Appendix J – Data Validation
5.2.2. Sample Handling
ITEM QUESTION YES NO (Comment
below)
1 Were the sample holding times met?
2 Were the samples in proper custody between the field and reaching
the laboratory?
3 Were the samples properly and adequately preserved?
This includes keeping the samples chilled, where applicable.
4 Were the samples received by the laboratory in good condition?
Comments
Nil
Sample Handling was: Satisfactory
Partially Satisfactory
Unsatisfactory
5.2.3. Laboratory (Method) Blanks
The method blank allows assessment for potential method bias for relevant analytes. A method blankis the component of the analytical signal from each analytical method that is from laboratoryequipment (reagents, glassware and analytical instruments etc.). The method blank is determined bythe laboratories through running solvents and reagents in exactly the same manner as the samples.
At least one method blank should be run per 20 samples analysed, with a minimum of one methodblank per sample batch.
All laboratory method blank results reported concentrations of contaminants below the laboratoryreporting limits.
5.2.4. Laboratory Duplicates
To provide an estimate of the analysis method precision and duplicate sample heterogeneity, asample from the same batch is duplicated and analysed for a targeted analyte.
100% of internal laboratory duplicates analysed were within acceptable limits (<30% RPD).
Appendix J – Data Validation
5.2.5. Laboratory Control Samples
Laboratory control samples are prepared in the laboratory and comprise either a known analyteconcentration within a proven matrix or a control matrix spiked with analytes representative of thetarget analyte. The laboratory control sample percent recovery is reported along with the primarysample data to assess method accuracy for all targeted analytes.
Laboratory control samples are required to be processed per 20 samples analysed, with a minimum ofone laboratory control sample run per batch of samples.
54 out of 56 (96.4%) of laboratory control sample analyses were within the acceptable range (>50%).
5.2.6. Matrix Spikes
A matrix spike is undertaken to document the effect of the matrix on the performance of the methodused. The matrix spike is the addition of a known analyte concentration to the target matrix prior toextraction or digestion. If a poor percentage recovery of a matrix spike is reported below the expectedanalytical method performance, the laboratory should investigate the likely cause. If, afterinvestigation, the poor matrix spike remains and is reported to the client, an explanation documentingthe limitations of the method for recovery of the target analyte from that particular matrix needs to beprovided. If the laboratory control sample recovery is acceptable for the same analyte, this mayindicate that it is the matrix causing the poor recovery and not the method.
82 out of 84 (98%) of matrix spike recoveries were within acceptable limits.
5.2.7. Surrogate Recoveries
Surrogate spikes are a means of the laboratory checking that no gross errors have taken placethroughout the analysis procedure, causing losses of the target analytes. The laboratory undertakessurrogate spikes by adding a known quantity of compounds with similar properties and behaviour tothe target compounds, but which are not expected to be found in field samples.
Surrogate spikes are only appropriate for organic analysis and are added to all samples beinganalysed prior to the extraction process. A percent recovery is calculated for each surrogate,providing the analytical method accuracy of extraction of the target analytes from samples.
The collated laboratory data for surrogate recoveries reported 109 surrogates (out of a total of 690surrogate analyses undertaken) outside acceptance targets. These discrepancies were for a numberof PFAS compounds, however only two of these discrepancies were for key compounds (one forPFOS and one for PFOA) indicating that the data set was acceptable for the purposes of supportingthe outcomes of the report.
5.2.8. Summary of Internal Laboratory Quality Control
A summary of the internal laboratory quality control results is provided in Table 4 and Table 5.
Appendix J – Data Validation
Table 10: Summary of Internal Laboratory Quality Control
ITEM QUESTION YES NO (Comment
above)
1 Were the laboratory blanks/reagents blanks free of contamination?
2 Were the spike recoveries within control limits?
3 Were the RPDs of the laboratory duplicates within control limits?
4 Were the surrogate recoveries within control limits?
Table 11: Summary of internal laboratory QC results
QC test Total Analyses Number outside of
Acceptable Criteria
% of analyses acceptable
Method Blanks 28 0 100%
Laboratory Duplicates 84 0 100%
Laboratory Control Samples 56 2 96.4%
Matrix Spikes 84 2 98%
Surrogates 690 109 (2 for PFOS,
PFOA or PFHxS)
84% (99%)
Totals 970 113 (6) 89% (99%)
The review of the laboratory internal quality control testing undertaken indicated that the overallcompleteness for the internal laboratory quality control results was 69.7%. However as most of thesurrogate outlies are not for key PFAS compounds and without the precursor and fluorotelemersurrogate outliers reported, over 99% of internal laboratory quality control results were acceptable.The data is therefore considered of an acceptable quality to use in the report.
Laboratory internal QA/QC was: Satisfactory
Partially Satisfactory
Unsatisfactory
5.3. Summary of August 2018 aquatic invertebrates,reptiles and mammals data quality review
In general, the data quality of the terrestrial invertebrate sampling was considered to be acceptable.Surrogate recoveries were poor for precursor compounds and fluorotelemers, but suitable for PFOSand PFOA, which are the compounds applied quantitatively in this risk assessment.
Ecological Risk AssessmentAugust 2018 SamplingQuality Control - RPDs
DoD, RAAF Base Tindal
Lab Report Number 612989 612989 612989 612989 612989 612989 612989 ES1824883 612989 ES1825854
Field ID0990_FH557_
1808150990_FH559_
180815 RPD0990_TV112_
1808140990_TV113_
180814 RPD0990_SD276
_1808140990_SD277
_180814 RPD0990_TV118_
1808150990_TV119_
180815 RPD0990_FH555_
1808150990_FH555_
180815 RPDSampled Date/Time 15/08/2018 15/08/2018 14/08/2018 14/08/2018 14/08/2018 14/08/2018 15/08/2018 15/08/2018 15/08/2018 15/08/2018
Chem_GroupChemName Units EQL
PFAS 2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 01H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 01H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 01H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 01H.1H.2H.2H-perfluorododecanesulfonic acid µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-octanoic acid (PFOA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluoro-n-hexane sulfonic acid (PFHxS) µg/kg 0.3 (Primary): 1 (Interlab) <0.3 <0.3 0 <0.3 <0.3 0 <0.3 <1.0 0 <0.3 <1.0 0 0.6 <1.0 0Perfluoro-n-octane sulfonic acid (PFOS) µg/kg 0.3 (Primary): 1 (Interlab) 12.0 16.0 29 <0.3 <0.3 0 <0.3 <1.0 0 <0.3 <1.0 0 14.0 13.0 7Perfluorobutane sulfonic acid (PFBS) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluorobutanoic acid (PFBA) µg/kg 0.5 (Primary): 5 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <5.0 0 <0.5 <5.0 0 <0.5 <5.0 0Perfluoro-n-decane sulfonic acid (PFDS) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-decanoic acid (PFDA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluoro-n-dodecanoic acid (PFDoDA) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-heptane sulfonic acid (PFHpS) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluoro-n-heptanoic acid (PFHpA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluoro-n-hexanoic acid (PFHxA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluoro-n-nonanoic acid (PFNA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0Perfluorooctan esulfonamide (PFOSA) µg/kg 0.5 (Primary): 5 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <5.0 0 <0.5 <5.0 0 <0.5 <5.0 0Perfluoro pentanoic acid (PFPeA) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-tetradecanoic acid (PFTeDA) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-tridecanoic acid (PFTriDA) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0Perfluoro-n-undecanoic acid (PFUnDA) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0N-Ethyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0N-Methyl perfluorooctane sulfonamidoacetic acid µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0 <0.5 <2.0 0N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/kg 0.5 (Primary): 5 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <5.0 0 <0.5 <5.0 0 <0.5 <5.0 0Perfluoropentane sulfonic acid (PFPeS) µg/kg 0.5 (Primary): 1 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <1.0 0 <0.5 <1.0 0 <0.5 <1.0 0N-Me perfluorooctanesulfonamid oethanol µg/kg 0.5 (Primary): 2 (Interlab) <0.5 <0.5 0 <0.5 <0.5 0 <0.5 <2.0 0 <0.5 <2.0 0
*RPDs have only been considered where a concentration is greater than 0 times the EQL.**High RPDs are in bold (Acceptable RPDs for each EQL multiplier range are: 50 (0-10 x EQL); 50 (10-20 x EQL); 30 ( > 20 x EQL) )***Interlab Duplicates are matched on a per compound basis as methods vary between laboratories. Any methods in the row header relate to those used in the primary laboratory
Ecological Risk AssessmentAugust 2018 SamplingQuality Control - Blanks
DoD, RAAF Base Tindal
Lab Report Number 612989 612989 612989Field ID 0990_QC300_180815 0990_QC301_180815 0990_QC302_180815Sampled_Date/Time 15/08/2018 15/08/2018 15/08/2018Sample Type Rinsate Trip_B Trip_B
Chem_Group ChemName Units EQL
PFAS 2-(N-ethylperfluoro-1-octane sulfonamide)-ethanol µg/L 0.05 <0.05 <0.05 <0.051H.1H.2H.2H-perfluorohexanesulfonic acid (4:2 FTS) µg/L 0.01 <0.01 <0.01 <0.011H.1H.2H.2H-perfluorooctanesulfonic acid (6:2 FTS) µg/L 0.05 <0.05 <0.05 <0.051H.1H.2H.2H-perfluorodecanesulfonic acid (8:2 FTS) µg/L 0.01 <0.01 <0.01 <0.011H.1H.2H.2H-perfluorododecanesulfonic acid µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-octanoic acid (PFOA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-hexane sulfonic acid (PFHxS) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-octane sulfonic acid (PFOS) µg/L 0.01 <0.01 <0.01 <0.01Perfluorobutane sulfonic acid (PFBS) µg/L 0.01 <0.01 <0.01 <0.01Perfluorobutanoic acid (PFBA) µg/L 0.05 <0.05 <0.05 <0.05Perfluoro-n-decane sulfonic acid (PFDS) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-decanoic acid (PFDA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-dodecanoic acid (PFDoDA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-heptane sulfonic acid (PFHpS) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-heptanoic acid (PFHpA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-hexanoic acid (PFHxA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-nonanoic acid (PFNA) µg/L 0.01 <0.01 <0.01 <0.01Perfluorooctan esulfonamide (PFOSA) µg/L 0.05 <0.05 <0.05 <0.05Perfluoro pentanoic acid (PFPeA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-tetradecanoic acid (PFTeDA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-tridecanoic acid (PFTriDA) µg/L 0.01 <0.01 <0.01 <0.01Perfluoro-n-undecanoic acid (PFUnDA) µg/L 0.01 <0.01 <0.01 <0.01N-Ethyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05 <0.05 <0.05N-Methyl perfluorooctane sulfonamidoacetic acid µg/L 0.05 <0.05 <0.05 <0.05N-Ethylperfluoro-1-octane sulfonamide (N-EtFOSA) µg/L 0.05 <0.05 <0.05 <0.05N-methylperfluoro-1-octane sulfonamide (N-MeFOSA) µg/L 0.05 <0.05 <0.05 <0.05PFHxS and PFOS (Sum of Total) µg/L 0.01 <0.01 <0.01 <0.01Perfluoropentane sulfonic acid (PFPeS) µg/L 0.01 <0.01 <0.01 <0.01N-Me perfluorooctanesulfonamid oethanol µg/L 0.05 <0.05 <0.05 <0.05Sum of PFAS µg/L 0.1 <0.1 <0.1 <0.1Sum of PFAS (WA DER List) µg/L 0.05 <0.05 <0.05 <0.05